Coq and Rabeprazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Coq (coenzyme q - 10) and Rabeprazole (rabeprazole sodium). Common drug interactions include asthenia among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Coq and Rabeprazole. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Coq?

Coq has active ingredients of coenzyme q - 10. It is often used in high blood cholesterol. eHealthMe is studying from 11,465 Coq users. Check the latest studies of Coq.

What is Rabeprazole?

Rabeprazole has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 31,689 Rabeprazole users. Check the latest studies of Rabeprazole.



On Aug, 01, 2026

19 people who take Coq and Rabeprazole together, and have interactions are studied.

Coq and Rabeprazole drug interactions.

What are the common drug interactions of Coq and Rabeprazole, by gender? *:

female:

  1. Asthenia (weakness)
  2. Dizziness
  3. Lymphoma (cancer that begins in immune system cells)
  4. Vomiting
  5. Activities of daily living impaired
  6. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  7. Anxiety
  8. Arthralgia (joint pain)
  9. Bacterial infection
  10. Balance disorder

male:

  1. Fatigue (feeling of tiredness)
  2. Chills (felling of cold)
  3. Rib fracture
  4. Seasonal allergy (allergic condition due to certain season)
  5. Somnolence (a state of near-sleep, a strong desire for sleep)
  6. Thermal burn (burn by heat)
  7. Tremor (trembling or shaking movements in one or more parts of your body)
  8. Peripheral swelling
  9. Hypertension (high blood pressure)
  10. Stress

What are the common drug interactions of Coq and Rabeprazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  2. Vitamin d deficiency

40-49:

  1. Anxiety
  2. Arthralgia (joint pain)
  3. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  4. Fatigue (feeling of tiredness)
  5. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  6. Migraine (headache)
  7. Myalgia (muscle pain)

50-59:

  1. Fall
  2. Headache (pain in head)
  3. Chills (felling of cold)
  4. Fatigue (feeling of tiredness)
  5. Hangover
  6. Infusion related reaction
  7. Nasopharyngitis (inflammation of the nasopharynx)
  8. Neck pain
  9. Neuropathy peripheral (surface nerve damage)
  10. Oropharyngeal pain

60+:

  1. Lymphoma (cancer that begins in immune system cells)
  2. Pneumonia
  3. Dizziness
  4. Eye infection
  5. Fatigue (feeling of tiredness)
  6. Gait disturbance
  7. Haemoglobin decreased
  8. Hospitalisation
  9. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  10. Illogical thinking

What are the existing conditions these people have? *

  1. Indigestion: 2 people, 10.53%
  2. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 10.53%
  3. Multifocal Motor Neuropathy (a progressively worsening condition where muscles in the extremities gradually weaken): 2 people, 10.53%
  4. Migraine (headache): 2 people, 10.53%
  5. High Blood Pressure: 1 person, 5.26%
  6. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 5.26%
  7. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 1 person, 5.26%
  8. Dizziness: 1 person, 5.26%
  9. Endocrine Ophthalmopathy (increased water content of retroocular orbital tissues; associated with thyroid disease, usually hyperthyroidism): 1 person, 5.26%
  10. Eye Disorder: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Coq and Rabeprazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Coq and Rabeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Coq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Rabeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Coq and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rabeprazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on coenzyme q - 10 and rabeprazole sodium (the active ingredients of Coq and Rabeprazole, respectively), and Coq and Rabeprazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: